These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1190 related items for PubMed ID: 23456653

  • 1. B-cell targeted therapies in systemic lupus erythematosus: successes and challenges.
    Harvey PR, Gordon C.
    BioDrugs; 2013 Apr; 27(2):85-95. PubMed ID: 23456653
    [Abstract] [Full Text] [Related]

  • 2. B cell-targeted therapies for systemic lupus erythematosus: an update on clinical trial data.
    Looney RJ.
    Drugs; 2010 Mar 26; 70(5):529-40. PubMed ID: 20297867
    [Abstract] [Full Text] [Related]

  • 3. B-cell-targeted therapy for systemic lupus erythematosus.
    Sabahi R, Anolik JH.
    Drugs; 2006 Mar 26; 66(15):1933-48. PubMed ID: 17100405
    [Abstract] [Full Text] [Related]

  • 4. B-cell-targeted therapy for systemic lupus erythematosus: an update.
    Ding C, Foote S, Jones G.
    BioDrugs; 2008 Mar 26; 22(4):239-49. PubMed ID: 18611066
    [Abstract] [Full Text] [Related]

  • 5. Phase III, multicentre, randomised, double-blind, placebo-controlled, 104-week study of subcutaneous belimumab administered in combination with rituximab in adults with systemic lupus erythematosus (SLE): BLISS-BELIEVE study protocol.
    Teng YKO, Bruce IN, Diamond B, Furie RA, van Vollenhoven RF, Gordon D, Groark J, Henderson RB, Oldham M, Tak PP.
    BMJ Open; 2019 Mar 20; 9(3):e025687. PubMed ID: 30898822
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of biologic therapies for systemic lupus erythematosus treatment: systematic review and meta-analysis.
    Borba HH, Wiens A, de Souza TT, Correr CJ, Pontarolo R.
    BioDrugs; 2014 Apr 20; 28(2):211-28. PubMed ID: 24190520
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of Epratuzumab, an Anti-CD22 Monoclonal IgG Antibody, in Systemic Lupus Erythematosus Patients With Associated Sjögren's Syndrome: Post Hoc Analyses From the EMBODY Trials.
    Gottenberg JE, Dörner T, Bootsma H, Devauchelle-Pensec V, Bowman SJ, Mariette X, Bartz H, Oortgiesen M, Shock A, Koetse W, Galateanu C, Bongardt S, Wegener WA, Goldenberg DM, Meno-Tetang G, Kosutic G, Gordon C.
    Arthritis Rheumatol; 2018 May 20; 70(5):763-773. PubMed ID: 29381843
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double-Blind, Placebo-Controlled Trials.
    Clowse ME, Wallace DJ, Furie RA, Petri MA, Pike MC, Leszczyński P, Neuwelt CM, Hobbs K, Keiserman M, Duca L, Kalunian KC, Galateanu C, Bongardt S, Stach C, Beaudot C, Kilgallen B, Gordon C, EMBODY Investigator Group.
    Arthritis Rheumatol; 2017 Feb 20; 69(2):362-375. PubMed ID: 27598855
    [Abstract] [Full Text] [Related]

  • 9. Safety and efficacy of belimumab after B cell depletion therapy in systemic LUPUS erythematosus (BEAT-LUPUS) trial: statistical analysis plan.
    Muller P, Chowdhury K, Gordon C, Ehrenstein MR, Doré CJ.
    Trials; 2020 Jul 16; 21(1):652. PubMed ID: 32677992
    [Abstract] [Full Text] [Related]

  • 10. Systematic review, and meta-analysis of steroid-sparing effect, of biologic agents in randomized, placebo-controlled phase 3 trials for systemic lupus erythematosus.
    Oon S, Huq M, Godfrey T, Nikpour M.
    Semin Arthritis Rheum; 2018 Oct 16; 48(2):221-239. PubMed ID: 29426575
    [Abstract] [Full Text] [Related]

  • 11. Targeted B cell therapies in the treatment of adult and pediatric systemic lupus erythematosus.
    Hui-Yuen JS, Nguyen SC, Askanase AD.
    Lupus; 2016 Sep 16; 25(10):1086-96. PubMed ID: 27497253
    [Abstract] [Full Text] [Related]

  • 12. Current role of rituximab in systemic lupus erythematosus.
    Mok CC.
    Int J Rheum Dis; 2015 Feb 16; 18(2):154-63. PubMed ID: 25522652
    [Abstract] [Full Text] [Related]

  • 13. [Recombinant proteins or monoclonal antibodies: comparative properties and interest in systemic lupus erythematosus].
    Terrier B, Mouthon L.
    Med Sci (Paris); 2013 Jan 16; 29(1):65-73. PubMed ID: 23351696
    [Abstract] [Full Text] [Related]

  • 14. The NET-effect of combining rituximab with belimumab in severe systemic lupus erythematosus.
    Kraaij T, Kamerling SWA, de Rooij ENM, van Daele PLA, Bredewold OW, Bakker JA, Bajema IM, Scherer HU, Toes REM, Huizinga TJW, Rabelink TJ, van Kooten C, Teng YKO.
    J Autoimmun; 2018 Jul 16; 91():45-54. PubMed ID: 29636274
    [Abstract] [Full Text] [Related]

  • 15. Anti-CD22/CD20 Bispecific antibody with enhanced trogocytosis for treatment of Lupus.
    Rossi EA, Chang CH, Goldenberg DM.
    PLoS One; 2014 Jul 16; 9(5):e98315. PubMed ID: 24841238
    [Abstract] [Full Text] [Related]

  • 16. Successful sequential therapy with rituximab and belimumab in patients with active systemic lupus erythematosus: a case series.
    Gualtierotti R, Borghi MO, Gerosa M, Schioppo T, Larghi P, Geginat J, Meroni PL.
    Clin Exp Rheumatol; 2018 Jul 16; 36(4):643-647. PubMed ID: 29533753
    [Abstract] [Full Text] [Related]

  • 17. Epratuzumab for the treatment of systemic lupus erythematosus.
    Geh D, Gordon C.
    Expert Rev Clin Immunol; 2018 Apr 16; 14(4):245-258. PubMed ID: 29542345
    [Abstract] [Full Text] [Related]

  • 18. Belimumab after B cell depletion therapy in patients with systemic lupus erythematosus (BEAT Lupus) protocol: a prospective multicentre, double-blind, randomised, placebo-controlled, 52-week phase II clinical trial.
    Jones A, Muller P, Dore CJ, Ikeji F, Caverly E, Chowdhury K, Isenberg DA, Gordon C, Ehrenstein MR.
    BMJ Open; 2019 Dec 16; 9(12):e032569. PubMed ID: 31848169
    [Abstract] [Full Text] [Related]

  • 19. Belimumab: anti-BLyS human monoclonal antibody, anti-BLyS monoclonal antibody, BmAb, human monoclonal antibody to B-lymphocyte stimulator.
    Drugs R D; 2008 Dec 16; 9(3):197-202. PubMed ID: 18457473
    [Abstract] [Full Text] [Related]

  • 20. [What's new in internal medicine: emerging treatments for systemic lupus erythematosus].
    Hachulla É.
    Ann Dermatol Venereol; 2011 Dec 16; 138 Suppl 4():S241-4. PubMed ID: 22202645
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 60.